InsidersTradesSigma
Browse the complete record of transactions filed by O'Brien James Michael, Chief Financial Officer. Insider active across 1 companies, notably Cognition Therapeutics INC. In total, 2 disclosures have been published. Total volume traded: €103k. The latest transaction was disclosed on 13 October 2021 — Acquisition. Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
James Michael O'Brien is the Chief Financial Officer at COGNITION THERAPEUTICS INC. He oversees the financial operations of the company, including risk management and strategic planning. James plays a key role in financial strategy and the company's growth.